RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 1 034 JPY -6.43%
Market Cap: ¥25.3B

Operating Margin

-17.4%
Current
Declining
by 16.5%
vs 3-y average of -0.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-17.4%
=
Operating Income
¥-530.9m
/
Revenue
¥3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-17.4%
=
Operating Income
¥-530.9m
/
Revenue
¥3B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
RaQualia Pharma Inc
TSE:4579
25.3B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
222B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.3B EUR
Loading...

Market Distribution

Lower than 96% of companies in Japan
Percentile
4th
Based on 6 730 companies
4th percentile
-17.4%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

RaQualia Pharma Inc
Glance View

Market Cap
25.3B JPY
Industry
Pharmaceuticals

RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. The company is headquartered in Nagoya, Aichi-Ken and currently employs 67 full-time employees. The company went IPO on 2011-07-20. The firm is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The firm is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion partial agonist, among others.

Intrinsic Value
749.42 JPY
Overvaluation 28%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-17.4%
=
Operating Income
¥-530.9m
/
Revenue
¥3B
What is RaQualia Pharma Inc's current Operating Margin?

The current Operating Margin for RaQualia Pharma Inc is -17.4%, which is below its 3-year median of -0.9%.

How has Operating Margin changed over time?

Over the last 3 years, RaQualia Pharma Inc’s Operating Margin has decreased from 36% to -17.4%. During this period, it reached a low of -20.4% on Jun 30, 2024 and a high of 36% on Aug 30, 2022.

Back to Top